Diary - News
All news PRAGMA awared 1st prize from UK charity Action on Hearing Loss
PRAGMA Therapeutics awarded first prize and £300,000 from UK charity action on hearing loss to develop new drugs to treat hearing loss.
PRAGMA Therapeutics SAS, a leading biopharmaceutical company in the field of stress and trauma-related disorders, announced today that it has received a Translational Research Initiative for Hearing (TRIH) award from the charity Action on Hearing Loss to develop novel small molecule drugs for the treatment of Sensorineural Hearing Lossin both civilian and military patient populations.
To this end, PRAGMA has established an international collaboration with world-renowned Professor Robert Frisina, Director of the Global Center for Hearing & Speech Research at the University of South Florida, and principal investigator to perform efficacy studies in translational animal models of hearing loss
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree